Dr. Divine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3410 Worth St
Ste 400
Dallas, TX 75246Phone+1 214-370-1300Fax+1 214-370-1313- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gynecologic Oncology, 2014 - 2017
- University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 2010 - 2014
- University of Texas Medical Branch School of MedicineClass of 2010
Certifications & Licensure
- TX State Medical License 2017 - 2024
- MO State Medical License 2014 - 2018
- AL State Medical License Active through 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 37 citationsTWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.Whitney R. Grither, Laura M. Divine, E.H. Meller, Daniel Wilke, Riva A. Desai, Andrew J. Loza, Peinan Zhao, A. Lohrey, Gregory D. Longmore, Katherine Fuh> ;Oncogene. 2018 Jan 19
- 6 citationsTwo sisters with Mayer-Rokitansky-Küster-Hauser syndrome and serous adenocarcinoma of the ovary.Laura M. Divine, Christina Chu, David G. Mutch> ;Gynecologic Oncology Reports. 2017 Nov 1
- 22 citationsBenefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancerPratibha Binder, Lindsay M. Kuroki, Peinan Zhao, S.E. Cusworth, Laura M. Divine, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. ...> ;Gynecologic Oncology. 2017 Nov 1
- Join now to see all
Hospital Affiliations
- Baylor University Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: